Cargando…
E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases
E10A, a replication-defective adenovirus carrying human endostatin gene, has finished Phase I clinical trials for solid cancers. We assessed whether the combination of E10A with docetaxel would enhance antiangiogenic activities and inhibit prostate cancer growth and metastases. Combination use of co...
Autores principales: | Zhao, Peng, Luo, Rongcheng, Wu, Jiangxue, Xie, Fajun, Li, Hongli, Xiao, Xia, Fu, Liwu, Zhu, Xiaofeng, Liu, Ranyi, Zhu, Yinghui, Liang, Zhihui, Huang, Wenlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837610/ https://www.ncbi.nlm.nih.gov/pubmed/26065034 http://dx.doi.org/10.1111/j.1582-4934.2008.00548.x |
Ejemplares similares
-
Co-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancer
por: Qiu, Bo, et al.
Publicado: (2012) -
Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells
por: Li, Li-xia, et al.
Publicado: (2013) -
Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer
por: Yu, Hongyan, et al.
Publicado: (2013) -
Endostatin in the pancreas
por: Wigmore, S J
Publicado: (2005) -
Combination of oncolytic adenovirus targeting SATB1 and docetaxel for the treatment of castration-resistant prostate cancer
por: Mao, Lijun, et al.
Publicado: (2021)